HomeCancerLeukemia

Leukemia

Blinatumomab + Chemo Ups Survival in B-Cell Precursor Acute Lymphoblastic Leukemia

MONDAY, July 29, 2024 (HealthDay Information) — For grownup sufferers with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) who've measurable residual illness (MRD)-negative remission,...

Therapeutic choices for continual myeloid leukemia following the failure of second-generation tyrosine kinase inhibitor remedy

IntroductionThe first goal of treating continual section continual myeloid leukemia (CML-CP) is to stop development to extra aggressive accelerated or blast section CML,...

Again-to-Again Most cancers Diagnoses of Uterine Most cancers and Leukemia

44-year-old Hayley Shaw, a single mom of 1, was residing an energetic and wholesome life-style when her world was turned the wrong...

Fastened-Period Acalabrutinib/Venetoclax Yields PFS Profit vs SOC in Frontline CLL

Jennifer R. Brown, MD, PhDFastened-duration acalabrutinib (Calquence) plus venetoclax (Venclexta) with or with out obinutuzumab (Gazyva) within the frontline setting elicited a statistically...

Leukemia affected person meets his stem cell donor for the primary time – The Dallas Morning Information

Leukemia affected person meets his stem cell donor for the primary time  The Dallas Morning Information

Hot Topics